.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Federal Trade Commission
Cantor Fitzgerald
US Department of Justice
Express Scripts
Dow
Baxter
Cerilliant
McKesson
Teva

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018761

« Back to Dashboard
NDA 018761 describes ALUPENT, which is a drug marketed by Boehringer Ingelheim and is included in five NDAs. Additional details are available on the ALUPENT profile page.

The generic ingredient in ALUPENT is metaproterenol sulfate. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the metaproterenol sulfate profile page.

Summary for NDA: 018761

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;INHALATIONStrength0.6%
Approval Date:Jun 30, 1983TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION;INHALATIONStrength0.4%
Approval Date:Oct 10, 1986TE:RLD:No

Expired Orange Book Patents for NDA: 018761

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim
ALUPENT
metaproterenol sulfate
SOLUTION;INHALATION018761-001Jun 30, 19833,422,196► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Teva
Mallinckrodt
US Army
Moodys
QuintilesIMS
McKinsey
Merck
UBS
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot